If you have been reading about Reference standard and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-03-12. Numbers and descriptions here follow the published literature rather than marketing material.
Common laboratory methods for NMN include high-performance liquid chromatography with ultraviolet detection, liquid chromatography coupled to mass spectrometry, and nuclear magnetic resonance spectroscopy. Because the nicotinamide ring absorbs ultraviolet light, HPLC-UV at wavelengths near 260 nm can be used for purity assessment. LC-MS and LC-MS/MS provide greater sensitivity and are often applied to biological samples. Identification typically relies on matching retention time, mass-to-charge ratio, and fragmentation pattern to a reference standard.
NMN is generally handled as a hygroscopic and light-sensitive solid in laboratory settings. Recommended storage is typically at -20°C or below, often under desiccation and protected from light. Aqueous solutions are less stable than the solid and may degrade through hydrolysis or other pathways, so fresh preparation is common for analytical work. Repeated freeze-thaw cycles can reduce sample integrity. Stability depends on pH, temperature, buffer composition, and the presence of metal ions, so specific shelf-life values should be determined experimentally rather than assumed.
Beyond its intracellular synthesis, NMN can be taken up from the extracellular environment, although the routes are still debated. Some evidence points to direct transport into cells through specific transporters, while other work suggests dephosphorylation to nicotinamide riboside followed by cellular uptake. Once inside, NMN can be converted to NAD+ by NMN adenylyltransferases; the relative contribution of these routes may differ by tissue, species, and experimental conditions. Researchers continue to investigate which mechanisms dominate in intact organisms and how they affect measured NAD+ levels. Direct measurement in tissues remains technically challenging because NMN can be rapidly metabolized during sample collection.
NMN occurs in many living systems, including bacteria, yeast, plants, and mammals. Dietary sources are present in foods such as edamame, avocado, broccoli, and various meats, but amounts vary widely and are generally lower than those used in research settings. Laboratory production often relies on enzymatic synthesis or chemical phosphorylation of nicotinamide riboside, and commercial material is typically supplied as a white to off-white powder. Because NMN is hygroscopic and sensitive to heat, moisture, and pH extremes, its handling requires care to preserve identity and purity. Aqueous preparation should be done with attention to pH and temperature to limit hydrolysis.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide found in cells. Its structure consists of a nicotinamide ring linked to ribose phosphate, and the compound serves as an intermediate in the salvage pathway for nicotinamide adenine dinucleotide, or NAD+. In this pathway, nicotinamide phosphoribosyltransferase converts nicotinamide and phosphoribosyl pyrophosphate into NMN, after which NMN adenylyltransferase attaches an adenylate group to produce NAD+. Because NAD+ participates in redox reactions and signaling, NMN occupies a central position in cellular metabolism. The molecule is distinct from nicotinamide riboside, though the two are related in NAD+ precursor research.
| Property | Value | Notes |
|---|---|---|
| Solubility | Water-soluble | Polar nucleotide |
| Typical storage | -20°C or below | Desiccated, protected from light |
| Common analytical method | HPLC-UV | Detection near 260 nm |
| Identity confirmation | LC-MS or NMR | Compared with reference standard |
| Purity assessment | HPLC peak area | Method-dependent |
Solid NMN is generally handled as a moisture-sensitive and light-sensitive material. Suppliers commonly recommend storage at minus 20 degrees Celsius in a sealed, desiccated container, protected from light. Aqueous solutions are less stable than the solid and may degrade faster at elevated temperatures or extreme pH values. Because NMN contains a phosphate ester and a glycosidic bond, hydrolysis and other degradation pathways are plausible under unfavorable conditions. Stability data from independent laboratories remain limited, so handling recommendations often reflect supplier practice rather than published consensus.
Analytical measurement of NMN typically uses high-performance liquid chromatography with ultraviolet detection, often at a wavelength near 260 nanometers. Liquid chromatography coupled with tandem mass spectrometry provides greater sensitivity and specificity, especially for biological samples. Nuclear magnetic resonance spectroscopy can confirm structure and detect certain impurities. Purity values reported by suppliers depend on the analytical method, calibration standards, and whether related compounds such as nicotinamide or NAD+ are included in the calculation. Independent verification is useful because supplement labels may not fully describe the tested material.
Regulatory treatment of NMN differs by country and has changed over time. In the United States, the Food and Drug Administration has stated that NMN is excluded from the definition of a dietary supplement because it was investigated as a drug before being marketed as a supplement; enforcement and legal interpretation continue to evolve. In the European Union, NMN may require authorization as a novel food before sale. In Japan, NMN has been marketed in some food products, while it is not approved as a therapeutic drug in major markets. These categories affect labeling, permitted claims, and quality oversight.
In the canonical salvage pathway, nicotinamide phosphoribosyltransferase, known as NAMPT, transfers a phosphoribosyl group to nicotinamide and releases NMN. A second enzyme, NMN adenylyltransferase, then attaches an adenylyl group to NMN to form NAD+. Alternative routes exist, including a pathway that uses nicotinamide riboside and its phosphorylated forms. The relative contribution of extracellular NMN to intracellular NAD+ pools remains an area of active investigation, and the roles of specific transporters and enzymes are not completely defined.
NMN is present in small amounts in various foods, including certain vegetables, fruits, and milk, though dietary quantities are generally low. Laboratory research often uses synthetic or enzymatically produced NMN. The compound has drawn interest because NAD+ levels decline with age in some tissues and because restoring NAD+ may affect metabolism in animal models. Whether oral NMN produces meaningful NAD+ increases in humans and whether such changes translate into health benefits are not fully established.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide base with a ribose sugar and a phosphate group. Within cells, NMN sits on the biosynthetic route that recycles nicotinamide back into nicotinamide adenine dinucleotide, or NAD+. Because NAD+ participates in redox reactions and signaling, enzymes that produce and consume it influence many metabolic processes. The compound is therefore best described as an intermediate rather than a final signaling molecule.
Quality control for NMN materials typically includes identity, assay, impurity, and residual solvent tests. Certificates of analysis may report HPLC purity, water content, heavy metals, and microbial limits depending on the intended use. Because commercial NMN is sold as a research chemical or ingredient rather than a standardized drug in many jurisdictions, specifications can vary between suppliers. Independent verification can involve comparing retention time, mass spectrum, and NMR data against a reference standard. Open questions remain about how best to standardize purity claims and biological potency across different production methods.
Analytical identification of NMN usually combines chromatographic separation with mass spectrometric detection. High-performance liquid chromatography coupled to tandem mass spectrometry is common for quantifying NMN in biological matrices and finished materials. Because NMN and related nucleotides share similar masses and retention behavior, method development must resolve potential interferences such as nicotinamide riboside and NAD+. Ultraviolet detection at approximately 260 nm can be used for purity checks when concentrations are sufficient. Nuclear magnetic resonance spectroscopy provides structural confirmation and can distinguish anomeric forms.
Stability testing examines how temperature, humidity, light, and pH affect NMN over time. The compound is generally considered hygroscopic and may degrade faster in aqueous solution than in dry powder form. Phosphate esters can hydrolyze under strongly acidic or alkaline conditions, and elevated temperatures accelerate such reactions. For storage, sealed containers at low temperature with desiccant are typical laboratory practices. Stability-indicating methods should separate NMN from its degradation products, including nicotinamide and nicotinamide riboside, so that purity loss can be tracked accurately.
Research on NMN has expanded because NAD+ concentrations decline with age in some tissues and because NAD+ participates in energy metabolism, DNA repair, and signaling. Animal studies have reported changes in NAD+ levels after NMN administration, but human data are more limited and often focus on safety, pharmacokinetics, and biomarker changes. Questions remain about oral absorption, tissue distribution, and whether changes in blood NAD+ reflect changes inside specific organs. NMN is not an approved drug, and claims about its clinical effects should be distinguished from established biochemical findings.
Nicotinamide mononucleotide, abbreviated NMN, is a naturally occurring nucleotide. Its structure combines a nicotinamide ring, a ribose sugar, and a phosphate group. The compound exists in cells as an intermediate in the production of nicotinamide adenine dinucleotide, a central redox cofactor. NMN is distinct from nicotinamide riboside, another related pyridine nucleotide, although the two compounds can converge in metabolic pathways. Its chemical formula is C11H15N2O8P, and it carries a net negative charge at physiological pH.
SLA did not exist prior to chemical synthesis in 1952. SLA is produced in equal amounts with RLA during achiral manufacturing processes. The racemic form was more widely used clinically in Europe and Japan in the 1950s to 1960s despite the early recognition that the various forms of LA are not bioequivalent. The first synthetic procedures appeared for RLA and SLA in the mid-1950s. Advances in chiral chemistry led to more efficient technologies for manufacturing the single enantiomers by both classical resolution and asymmetric synthesis and the demand for RLA also grew at this time. In the 21st century, R/S-LA, RLA and SLA with high chemical and/or optical purities are available in industrial quantities. At the current time, most of the world supply of R/S-LA and RLA is manufactured in China and smaller amounts in Italy, Germany, and Japan. RLA is produced by modifications of a process first described by Georg Lang in a Ph.D. thesis and later patented by Degussa. Although RLA is favored nutritionally due to its "vitamin-like" role in metabolism, both RLA and R/S-LA are widely available as dietary supplements. Both stereospecific and non-stereospecific reactions are known to occur in vivo and contribute to the mechanisms of action, but evidence to date indicates RLA may be the eutomer (the nutritionally and therapeutically preferred form).
Maapliv is a medication used to treat an acute decompensation episode (sudden worsening) of maple syrup urine disease. Maple syrup urine disease is an inherited disorder in which the body is unable to break down certain building blocks of protein known as branched-chain amino acids, including leucine, isoleucine and valine. As a result, these amino acids build up in the body, including in the brain, where leucine in particular can lead to brain damage. Maapliv is for use in people who cannot receive BCAA-free amino acids by mouth or via a feeding tube. Maapliv contains the amino acids L-alanine, L-arginine, L-aspartic acid, L-cysteine hydrochloride monodhydrate, L-glutamic acid, glycine, L-histidine, L-lysine, L-methionine, L-phenylalanine, L-proline, L-serine, taurine, L-threonine, L-tryptophan, and L-tyrosine. Maapliv is indicated for the treatment of maple syrup urine disease presenting with an acute decompensation episode in people from birth who are not eligible for an oral and enteral branched- chain amino acids free (BCAA- free) formulation. Maapliv was authorized for medical use in the European Union in July 2025.
{\displaystyle {\frac {1}{\sqrt {f_{\mathrm {D} }}}}=-2\,\log _{10}\left({\frac {2.51}{\mathrm {Re} {\sqrt {f_{\mathrm {D} }}}}}\left\{1+0.305R_{*}\;\left(1-\exp {\frac {-R_{*}}{26}}\right)\right\}\right),}
The preparation of other cuprates is more difficult than the YBCO preparation. They also have a different crystal structure: they are tetragonal where YBCO is orthorhombic. Problems in these superconductors arise because of the existence of three or more phases having a similar layered structure. Moreover, the crystal structure of other tested cuprate superconductors are very similar. Like YBCO, the perovskite-type feature and the presence of simple copper oxide (CuO2) layers also exist in these superconductors. However, unlike YBCO, Cu–O chains are not present in these superconductors. The YBCO superconductor has an orthorhombic structure, whereas the other high-Tc superconductors have a tetragonal structure. There are three main classes of superconducting cuprates: bismuth-based, thallium-based and mercury-based. The second cuprate by practical importance is currently BSCCO, a compound of Bi–Sr–Ca–Cu–O. The content of bismuth and strontium creates some chemical issues. It has three superconducting phases forming a homologous series as Bi2Sr2Can−1CunO4+2n+x (n=1, 2 and 3). These three phases are Bi-2201, Bi-2212 and Bi-2223, having transition temperatures of 20 K (−253.2 °C), 85 K (−188.2 °C) and 110 K (−163 °C), respectively, where the numbering system represent number of atoms for Bi Sr, Ca and Cu respectively. The two phases have a tetragonal structure which consists of two sheared crystallographic unit cells.
Sources: en.wikipedia.org
While working at St Mary's Hospital, London in 1928, Alexander Fleming, a Scottish physician, was investigating the variation of growth in cultures of S. aureus, trying to replicate research from Trinity College Dublin. He spent the summer break with his family at his country home The Dhoon at Barton Mills, Suffolk. Before leaving his laboratory at the end of July, he inoculated several culture plates with S. aureus. He kept the plates aside on one corner of the table away from direct sunlight and to make space for his research student, Stuart Craddock, to work in his absence. He returned to his laboratory on 3 September. As he and Daniel Merlin Pryce, his former research student, examined the culture plates, they found one with an open lid and the culture contaminated with a blue-green mould. In the contaminated plate the bacteria around the mould did not grow, while those farther away grew normally, meaning that the mould killed the bacteria. Fleming photographed the culture and took a sample of the mould for identification. Fleming resumed his vacation and returned to St Mary's that month. He collected the original mould and grew it in culture plates. After four days he found that the plates developed large colonies of the mould. He repeated the experiment with the same bacteria-killing results. He concluded that the mould was releasing a substance that was inhibiting bacterial growth. On testing against different bacteria, he found that the mould could kill only certain Gram-positive bacteria.
Logan's Roadhouse serves American food. The chain's menu includes mesquite-grilled steaks, traditional American fare (sandwiches, soup, salads, and seafood), ice-cold longneck beer, homemade yeast rolls, and unlimited buckets of in-shell peanuts. Logan's serves appetizers, steak, and hamburgers, and offers side dishes such as salad, french fries, homestyle potato chips, rice pilaf and sweet or baked potatoes.
However, Chaz Williams has disputed those accounts, stating that although the confrontation became physical, neither man was injured and both parties ultimately walked away without a scratch. Another incident took place at The Hit Factory a month later: As 50 Cent and members of G-Unit were recording upstairs, while Ja Rule and members of Murder Inc. were downstairs in another studio section. The two crews later discovered their proximity, and a fight later ensued. In the midst of the brawl, Murder Inc. affiliate Black Child stabbed several combatants, including 50 Cent. Despite being formally charged, Black Child claimed self-defense in the incident, and was later acquitted of any charges following the stabbing. Tensions continued to further escalate for 50 Cent following the studio brawl, as he had still maintained ties to numerous drug kingpins around Queens.
Sources: en.wikipedia.org
Legio XIV Gemina Martia Victrix (Twin martial and victorious): 57 BC – 48 BC: Julius Caesar, destroyed and reconstituted in 53 BC. Reconstituted by Octavian after 41 BC. Legio XV Apollinaris (Apollo's) 41 BC – 40 BC, Octavian, raised to end the occupation of Sicily by Sextus Pompeius. Legio XVI Gallica (Gallic) 41 BC – 40 BC, Octavian, disbanded after Batavian revolt in AD 70. Legio XVII raised by Octavian in 41 BC, destroyed in Teutoburg forest in AD 9 with XVIII and XIX legions. Legio XVIII raised by Octavian in 41 BC, destroyed in Teutoburg forest in AD 9 with XVII and XIX legions Legio XIX raised by Octavian in 41 BC, destroyed in Teutoburg forest in AD 9 with XVII and XVIII legions Legio XX Valeria Victrix (Victorious Valeria) raised by Octavian in 31 BC. Legio XX Siciliana: 36 BC – 6 BC, Octavian probably for his campaign against Sextus Pompey. Legio XXI Rapax (Predator) raised by Octavian in 31 BC Legio XXV: 49 BC – 42 BC, Julius Caesar Legio XXVI: 49 BC – 30 BC, Julius Caesar legio XXVII: 49 BC – 30 BC, Julius Caesar Legio XXVIII: 47 BC – 31 BC, Julius Caesar Legio XXIX: 49 BC – 30 BC, Julius Caesar Legio XXX Classica (Naval): 48 BC – 41 BC, Julius Caesar
A snakebite is an injury caused by the bite of a snake. Most snake species are non-venomous, but bites from venomous snakes may result in envenomation, in which venom is injected into the victim. A common sign of a bite from a venomous snake is the presence of two puncture wounds from the animal's fangs. Envenomation may cause redness, swelling, and severe pain around the bite, which may take up to an hour to develop. Vomiting, blurred vision, tingling of the limbs, and sweating may result. Most bites are on the hands, arms, or legs. Fear following a bite is common with symptoms of a racing heart and feeling faint. The venom may cause bleeding, kidney failure, a severe allergic reaction, tissue death around the bite, or breathing problems. Bites may result in the loss of a limb or other chronic problems or even death. The outcome depends on the type of snake, the area of the body bitten, the amount of snake venom injected, the general health of the person bitten, and whether or not anti-venom serum has been administered in a timely manner. Problems are often more severe in children than adults, due to their smaller size. Allergic reactions to snake venom can further complicate outcomes and can include anaphylaxis, requiring additional treatment and in some cases resulting in death. Snakes bite acts both as a method of hunting and as a means of protection. Risk factors for bites include working outside with one's hands such as in farming, forestry, and construction.
=== Europe === Marketing authorisation for 177Lu-DOTATATE was granted by the European Medicines Agency on 26 September 2017. 90Y-DOTATOC (international nonproprietary name: yttrium (90Y) edotreotide) and 177Lu-DOTATOC are designated as orphan drugs, but have not yet received marketing authorisation.
The Mediterranean coast was well known to the Carthaginians. Their close relations with Phoenician-Punic settlements and shared cultural ties likely gave them considerable political and economic influence there from the 6th or 5th century BC, alongside the establishment of unequal treaties with Iberian city-states. After Carthage's defeat by Rome in the First Punic War, it sought new western territories, culminating in the Barcid conquest of the Iberian Peninsula in 237 BC. The Romans invaded the Iberian Peninsula in 218 BC and expelled the Carthaginians after the Battle of Ilipa in 206 BC. Within 200 years, mainland Portugal had been annexed by the Romans despite resistance from local tribes such as the Lusitanians under the leadership of Viriathus and other leaders. In 409, with the decline of the Western Roman Empire, the Iberian Peninsula was invaded by Germanic tribes. Western Iberia was integrated into the Suebian Kingdom, with its capital in or near Braga. The Visigoths defeated the Suebi in 585 and ruled the peninsula until the early 8th century. In 711, the Iberian Peninsula was invaded from the south by the Umayyad Caliphate, which expanded rapidly. By 716, present-day mainland Portugal was part of the Muslim Iberian territories known as al-Andalus.
Sources: en.wikipedia.org
NMN is commonly detected by HPLC-UV, LC-MS, or LC-MS/MS. These methods separate the compound from related substances and identify it by retention time and mass.
Laboratory samples are typically stored at -20°C or below, protected from light and moisture. Solutions are usually prepared fresh because they can degrade more quickly than the solid.
Purity depends on the analytical method, detection wavelength, and integration parameters. A value from one laboratory may not be directly comparable to another without method details.
NMN is nicotinamide mononucleotide, a nucleotide intermediate in NAD+ biosynthesis. It consists of nicotinamide, ribose, and phosphate groups.